Dr. Ricardo Osorio | Medicine and Dentistry | Best Researcher Award
NYU Grossman School of Medicine, United States
Dr. Ricardo Osorio is a distinguished neuropsychiatrist and researcher specializing in the intersection of sleep, aging, and neurodegenerative disorders, particularly Alzheimer’s disease. He earned his M.D. from Universidad Autónoma de Madrid (Spain) in 2001, followed by multiple master’s degrees in Psychotherapy, Neuroscience, and Neuropsychology from Universidad Comillas and Universidad Complutense, Madrid, with a focus on executive function and cognitive aging. His clinical training includes residencies in psychiatry at 12 de Octubre Hospital, Madrid, internships in neurology at McGill University, Montreal, and neuropsychiatry at the Institute of Neurology, London, as well as postdoctoral neuroscience training at NYU Langone Health. Dr. Osorio’s professional career encompasses roles as attending psychiatrist in several Spanish hospitals, research scientist at Alzheimer’s Project Research Unit (CIEN Foundation) in Madrid, and progressive academic appointments at NYU School of Medicine and the Healthy Brain Aging and Sleep Center, where he is now a tenured associate professor. His research interests focus on sleep disorders as risk factors for neurodegeneration, slow-wave sleep and sleep spindle physiology, memory consolidation, and advanced neuroimaging techniques including PET imaging of glucose metabolism, amyloid, and tau in normal aging, cognitive decline, and Alzheimer’s disease. He possesses expertise in clinical psychiatry, cognitive assessment, neuroimaging analysis, sleep research methodologies, and interdisciplinary translational research. Dr. Osorio has received numerous awards and honors, including international fellowships, the Spanish National Psychiatry Residents Research Award, the Anne Elizabeth Suratt Young Investigator Award, and departmental mentorship recognitions. He has authored 130 publications, accumulated 9,893 citations, and holds an h-index of 44, reflecting his impactful contributions to science and clinical practice. Dr. Osorio’s work bridges neuroscience and clinical application, advancing understanding of cognitive aging, informing early detection strategies for Alzheimer’s disease, and contributing to the development of interventions that benefit patients and society at large, marking him as a leading figure in neuropsychiatric research and aging studies.
Profiles: Scopus | ORCID
Featured Publications
-
Bernard, M. A., Boutajangout, A., Debure, L., Ahmed, W., Briggs, A. Q., Boza-Calvo, C., Vedvyas, A., Marsh, K., Bubu, O. M., Osorio, R. S., et al. (2024, July 10). The relationship between anxiety and levels of Alzheimer’s disease plasma biomarkers. Preprint.
-
Iosifescu, D. V., Song, X., Gersten, M. B., Adib, A., Cho, Y., Collins, K. M., Yates, K. F., Hurtado-Puerto, A. M., McEachern, K. M., Osorio, R. S., et al. (2023, July 13). Protocol report on the transcranial photobiomodulation for Alzheimer’s disease (TRAP-AD) study. Healthcare, 11(14), 2017.
-
Parasoglou, P., Osorio, R. S., Khegai, O., Kovbasyuk, Z., Miller, M., Ho, A., Dehkharghani, S., Wisniewski, T., Convit, A., Mosconi, L., et al. (2022, December). Phosphorus metabolism in the brain of cognitively normal midlife individuals at risk for Alzheimer’s disease. Neuroimage: Reports, 2, 100121.
-
Lal, C., Ayappa, I., Ayas, N., Beaudin, A. E., Hoyos, C., Kushida, C. A., Kaminska, M., Mullins, A., Naismith, S. L., Osorio, R. S., et al. (2022, August). The link between obstructive sleep apnea and neurocognitive impairment: An official American Thoracic Society workshop report. Annals of the American Thoracic Society, 19(8), 1250–1267.
-
Teipel, S., Bruno, D., Plaska, C. R., Heslegrave, A., Ramos-Cejudo, J., Osorio, R. S., Zetterberg, H., Blennow, K., & Pomara, N. (2021, October). Association of CSF sTREM2, a marker of microglia activation, with cholinergic basal forebrain volume in major depressive disorder. Journal of Affective Disorders, 295, 1017–1025.
Dr. Ricardo Osorio’s work advances the understanding of sleep and neurodegenerative disorders, particularly Alzheimer’s disease, by identifying early risk factors and therapeutic targets. His research bridges neuroscience and clinical practice, improving strategies for diagnosis, prevention, and intervention, thereby benefiting patients, healthcare systems, and society globally.